{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:17:33Z","timestamp":1782739053488,"version":"3.54.5"},"reference-count":25,"publisher":"Japanese Society for Pediatric Endocrinology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pediatr Endocrinol"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1297\/cpe.30.149","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T18:09:09Z","timestamp":1625854149000},"page":"149-153","source":"Crossref","is-referenced-by-count":2,"title":["Central diabetes insipidus developing in a 6-year-old patient 4 years after          the remission of unifocal bone Langerhans cell histiocytosis"],"prefix":"10.1297","volume":"30","author":[{"given":"Hisae","family":"Nakatani","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Musashino Red Cross Hospital,              Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Takasawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Developmental Biology,              Tokyo Medical and Dental University (TMDU), Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Kashimada","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Developmental Biology,              Tokyo Medical and Dental University (TMDU), Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Jichi Medical University              School of Medicine, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Oshiba","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Musashino Red Cross Hospital,              Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Nagasawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Musashino Red Cross Hospital,              Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"125","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Rigaud,              C, Barkaoui,                MA, Thomas,                C,              Bertrand, Y,                Lambilliotte,              A, Miron,                J, et al.            Langerhans cell histiocytosis: therapeutic strategy and outcome in a            30-year nationwide cohort of 1478 patients under 18\u00a0years of age.            Br J Haematol          2016;174: 887\u201398.","DOI":"10.1111\/bjh.14140"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Salotti,                JA,              Nanduri, V,                Pearce, MS,                Parker, L,                Lynn, R,                Windebank,              KP. Incidence            and clinical features of Langerhans cell histiocytosis in the UK and            Ireland. Arch Dis Child          2009;94: 376\u201380.","DOI":"10.1136\/adc.2008.144527"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Morimoto,                A, Oh,                Y, Shioda,                Y, Kudo,                K, Imamura,                T. Recent            advances in Langerhans cell histiocytosis. Pediatr Int          2014;56: 451\u201361.","DOI":"10.1111\/ped.12380"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Shioda,              Y, Adachi,                S,              Imashuku, S,                Kudo, K,                Imamura, T,                Morimoto,            A. Analysis of 43            cases of Langerhans cell histiocytosis (LCH)-induced central diabetes insipidus            registered in the JLSG-96 and JLSG-02 studies in Japan. Int J            Hematol          2011;94: 545\u201351.","DOI":"10.1007\/s12185-011-0965-x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Sakamoto,                K,              Morimoto, A,                Shioda, Y,                Imamura, T,                Imashuku,            S, Japan LCH Study            Group (JLSG) . Central diabetes insipidus in pediatric            patients with Langerhans cell histiocytosis: Results from the JLSG-96\/02            studies. Pediatr Blood Cancer          2019;66: e27454.","DOI":"10.1002\/pbc.27454"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Grois,              N, P\u00f6tschger,                U, Prosch,                H, Minkov,                M, Arico,                M, Braier,                J, et al.            DALHX- and LCH I and II Study Committee. Risk            factors for diabetes insipidus in langerhans cell histiocytosis.            Pediatr Blood Cancer          2006;46: 228\u201333.","DOI":"10.1002\/pbc.20425"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Morimoto,                A, Ishida,                Y, Suzuki,                N, Ohga,                S, Shioda,                Y, Okimoto,                Y, et al.            HLH\/LCH Committee of the Japanese Society of Pediatric            Hematology. Nationwide survey of single-system single site            Langerhans cell histiocytosis in Japan. Pediatr Blood            Cancer          2010;54: 98\u2013102.","DOI":"10.1002\/pbc.22224"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Morimoto,                A,                Shimazaki,              C, Takahashi,                S,                Yoshikawa,              K, Nishimura,                R, Wakita,                H, et al.            Japan LCH Study Group. Therapeutic outcome of            multifocal Langerhans cell histiocytosis in adults treated with the Special C regimen            formulated by the Japan LCH Study Group. Int J Hematol          2013;97: 103\u20138.","DOI":"10.1007\/s12185-012-1245-0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hayase,              T, Saito,                S, Shioda,                Y, Imamura,                T,              Watanabe, K,                Ohki, K,              et al. Analysis of the BRAF and MAP2K1            mutations in patients with Langerhans cell histiocytosis in Japan.            Int J Hematol          2020;112: 560\u20137.","DOI":"10.1007\/s12185-020-02940-8"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Maghnie,              M, Cosi,                G,              Genovese, E,                Manca-Bitti,              ML, Cohen,                A, Zecca,                S, et al.            Central diabetes insipidus in children and young adults.            N Engl J Med          2000;343: 998\u20131007.","DOI":"10.1056\/NEJM200010053431403"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Richards,                GE,                Thomsett,              MJ, Boston,                BA,                DiMeglio,              LA, Shulman,                DI,              Draznin,            M. Natural            history of idiopathic diabetes insipidus. J Pediatr          2011;159: 566\u201370.","DOI":"10.1016\/j.jpeds.2011.03.044"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Liu,              SY, Tung,                YC, Lee,                CT, Liu,                HM, Peng,                SF, Wu,                MZ, et al.            Clinical characteristics of central diabetes insipidus in Taiwanese            children. J Formos Med Assoc          2013;112: 616\u201320.","DOI":"10.1016\/j.jfma.2013.06.019"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Di                Iorgi, N,                Allegri,            AE, Napoli,                F,              Calcagno, A,                Calandra,            E, Fratangeli,                N, et al.            Central diabetes insipidus in children and young adults: etiological            diagnosis and long-term outcome of idiopathic cases. J Clin            Endocrinol Metab          2014;99: 1264\u201372.","DOI":"10.1210\/jc.2013-3724"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Werny,              D, Elfers,                C, Perez,                FA,              Pihoker, C,                Roth,            CL. Pediatric            central diabetes insipidus: brain malformations are common and few patients have            idiopathic disease. J Clin Endocrinol Metab          2015;100: 3074\u201380.","DOI":"10.1210\/jc.2015-1287"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Liu,              W, Hou,                J, Liu,                X, Wang,                L, Li,                G. Causes and            follow-up of central diabetes insipidus in children. Int J            Endocrinol          2019;2019: 5303765.","DOI":"10.1155\/2019\/5303765"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Aihara,              Y, Watanabe,                S, Amano,                K, Komatsu,                K, Chiba,                K, Imanaka,                K, et al.            Placental alkaline phosphatase levels in cerebrospinal fluid can have a            decisive role in the differential diagnosis of intracranial germ cell            tumors. J Neurosurg          2018;131: 687\u201394.","DOI":"10.3171\/2018.3.JNS172520"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Imura,              H, Nakao,                K,              Shimatsu, A,                Ogawa, Y,                Sando, T,                Fujisawa,            I, et al.            Lymphocytic infundibuloneurohypophysitis as a cause of central diabetes            insipidus. N Engl J Med          1993;329: 683\u20139.","DOI":"10.1056\/NEJM199309023291002"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Iwama,              S, Sugimura,                Y, Kiyota,                A, Kato,                T, Enomoto,                A, Suzuki,                H, et al.            Rabphilin-3A as a targeted autoantigen in lymphocytic            infundibulo-neurohypophysitis. J Clin Endocrinol Metab          2015;100: E946\u201354.","DOI":"10.1210\/jc.2014-4209"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Pollono,              D, Rey,                G, Latella,                A, Rosso,                D,              Chantada, G,                Braier,            J. Reactivation            and risk of sequelae in Langerhans cell histiocytosis. Pediatr            Blood Cancer          2007;48: 696\u20139.","DOI":"10.1002\/pbc.21145"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Bernstrand,                C,                Sandstedt,              B, Ahstr\u00f6m,                L, Henter,                JI. Long-term            follow-up of Langerhans cell histiocytosis: 39 years\u2019 experience at a single            centre. Acta Paediatr          2005;94: 1073\u201384.","DOI":"10.1080\/08035250510028263"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Titgemeyer,                C, Grois,                N, Minkov,                M,                Flucher-Wolfram,              B,                Gatterer-Menz,              I, Gadner,                H. Pattern            and course of single-system disease in Langerhans cell histiocytosis data from the            DAL-HX 83- and 90-study. Med Pediatr Oncol          2001;37: 108\u201314.","DOI":"10.1002\/mpo.1178"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Chow,              TW, Leung,                WK, Cheng,                FWT, Kumta,                SM, Chu,                WCW, Lee,                V, et al.            Late outcomes in children with Langerhans cell            histiocytosis. Arch Dis Child          2017;102: 830\u20135.","DOI":"10.1136\/archdischild-2016-312185"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Minkov,              M, Steiner,                M,                P\u00f6tschger,              U, Aric\u00f2,                M, Braier,                J,              Donadieu, J,              et al. International LCH Study            Group. Reactivations in multisystem Langerhans cell            histiocytosis: data of the international LCH registry. J            Pediatr          2008;153: 700\u20135, 705.e1\u20132.","DOI":"10.1016\/j.jpeds.2008.05.002"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. H\u00e9ritier,                S, Emile,                JF,                Barkaoui,              MA, Thomas,                C, Fraitag,                S,                Boudjemaa,              S, et al.            BRAF mutation correlates with high-risk Langerhans cell histiocytosis and            increased resistance to first-line therapy. J Clin            Oncol          2016;34: 3023\u201330.","DOI":"10.1200\/JCO.2015.65.9508"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Berres,              ML, Lim,                KP, Peters,                T, Price,                J,              Takizawa, H,                Salmon, H,              et al. BRAF-V600E expression in precursor            versus differentiated dendritic cells defines clinically distinct LCH risk            groups. J Exp Med          2014;211: 669\u201383.","DOI":"10.1084\/jem.20130977"}],"container-title":["Clinical Pediatric Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/30\/3\/30_2021-0010\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T23:55:57Z","timestamp":1625874957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/30\/3\/30_2021-0010\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1297\/cpe.30.149","relation":{},"ISSN":["0918-5739","1347-7358"],"issn-type":[{"value":"0918-5739","type":"print"},{"value":"1347-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"article-number":"2021-0010"}}